Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 4 of 25

RECRUITING NA

Characterization of Human Olfactory Amygdala Subregions exp2

NCT07074574

RECRUITING NA

Characterization of Human Olfactory Amygdala Subregions Exp3

NCT07060651

RECRUITING NA

Characterization of Human Olfactory Amygdala Subregions

NCT04699799

RECRUITING NA

REDUCE Trial- Reducing Prolapse Recurrence

NCT04880239

RECRUITING

Heart Transplantation - Renewal

NCT05521399

RECRUITING Phase 3

The COCOA-PAD II Trial

NCT04794530

RECRUITING

Chronic Pain in Rheumatoid Arthritis

NCT05038553

RECRUITING NA

Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness

NCT05038709

RECRUITING NA

Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure

NCT05100017

RECRUITING

PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health

NCT05358483

RECRUITING NA

Study in Parkinson Disease of Exercise

NCT04284436

RECRUITING NA

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

NCT05082402

RECRUITING Phase 4

Predicting Stroke Risk in ICAD With Novel MRI

NCT05515874

RECRUITING NA

High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy

NCT05006937

RECRUITING NA

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NCT04240561

RECRUITING NA

Neuromodulation and Neurorehabilitation for mTBI

NCT03819608

RECRUITING NA

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

NCT05056051

RECRUITING

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

NCT04616131

RECRUITING Phase 4

Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair

NCT04573504

RECRUITING

Optimizing Y90 Therapy for Radiation Lobectomy

NCT04390724

RECRUITING NA

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

NCT04228978

RECRUITING NA

Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke

NCT04312269

RECRUITING Phase 4

Investigational MRI Clinical Software and Hardware

NCT05215132

RECRUITING

The Effect of IBD Flares on Serum PSA

NCT03558048

RECRUITING

The Gut and Skin Microbiome in Vitiligo Disease Progression

NCT03577327

RECRUITING NA

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis

NCT04287647

RECRUITING

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

NCT03932279

RECRUITING NA

Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

NCT03871075

RECRUITING NA

Interpersonal Relationships Intervention and Cardiovascular Health

NCT03670368

RECRUITING NA

Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

NCT03401762

RECRUITING Phase 2

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

NCT03213041

RECRUITING Phase 2

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

NCT02847559

RECRUITING

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

NCT01644903

RECRUITING

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

NCT01531257

RECRUITING

Language in Primary Progressive Aphasia

NCT00537004

RECRUITING

Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

NCT00898131

RECRUITING

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

NCT00005095

ACTIVE NOT RECRUITING NA

Utilization of a Web-Based Application to Improve Patient Health Literacy and Reduce Clinic Visit Times in Holmium Laser Enucleation of the Prostate (HoLEP) Procedures and Kidney Stone Surgery

NCT07580391

ACTIVE NOT RECRUITING Phase 2

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

NCT06723457

ACTIVE NOT RECRUITING NA

A Multimedia Presentation to Augment the Informed Consent Process for Anesthesia for Patients Undergoing Scheduled Caesarian Delivery

NCT06945250

ACTIVE NOT RECRUITING NA

Encouraging Multiple PrEP Options for Women Engaged in PRimary Care

NCT06785038

ACTIVE NOT RECRUITING NA

Adaptive Messaging to Support Depression Self-Management

NCT06458192

ACTIVE NOT RECRUITING NA

Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults

NCT05325944

ACTIVE NOT RECRUITING Phase 1

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

NCT06410248

ACTIVE NOT RECRUITING NA

Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors

NCT05931874

ACTIVE NOT RECRUITING NA

Trial to Optimize Just-in-Time Adaptive Intervention for Binge Eating & Weight-related Behaviors

NCT06349460

ACTIVE NOT RECRUITING NA

Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

NCT05822219

ACTIVE NOT RECRUITING Phase 2

Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma

NCT06164275

ACTIVE NOT RECRUITING NA

Voice Activated Personal Assistant for Depression Among Older Adults

NCT06114485

ACTIVE NOT RECRUITING Phase 3

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

NCT05852054

← Previous Page 4 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.